Title : Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.

Pub. Date : 2022 Feb

PMID : 34935059






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Berberine RAD51 recombinase Homo sapiens
2 BER enhanced GEM-induced cytotoxicity, apoptosis and inhibition of migration, whilst attenuating the GEM-induced upregulation of phosphorylated Akt and Rad51 expression. Berberine RAD51 recombinase Homo sapiens
3 Knockdown of Rad51 enhanced GEM-induced cytotoxicity, whilst overexpression of Rad51 reversed the suppressed cell viability induced by BER and GEM. Berberine RAD51 recombinase Homo sapiens
4 Knockdown of Rad51 enhanced GEM-induced cytotoxicity, whilst overexpression of Rad51 reversed the suppressed cell viability induced by BER and GEM. Berberine RAD51 recombinase Homo sapiens
5 Inactivation of the PI3K/Akt pathway by LY294002 or BER enhanced GEM-induced cytotoxicity and downregulated Rad51 expression, whilst overexpression of constitutively active Akt restored Rad51 expression and cell viability that was previously decreased by BER and GEM. Berberine RAD51 recombinase Homo sapiens
6 Inactivation of the PI3K/Akt pathway by LY294002 or BER enhanced GEM-induced cytotoxicity and downregulated Rad51 expression, whilst overexpression of constitutively active Akt restored Rad51 expression and cell viability that was previously decreased by BER and GEM. Berberine RAD51 recombinase Homo sapiens